|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|---|---|
| Consultation | |||||
| REVENUES | |||||
| Medicine | |||||
| Patient services | |||||
| Total rEVENUES | |||||
| Cost of medicine sold | |||||
| Medical consumables | |||||
| Salaries and benefits | |||||
| Stock-based compensation | |||||
| Office supplies | |||||
| Vehicle expenses | |||||
| Utilities expenses | |||||
| Rentals and leases | |||||
| Advertising and promotion expenses | |||||
| Right-of-use assets amortization | |||||
| Lease liabilities interest expense | |||||
| Professional fee | |||||
| Change in fair value of warrant liability | |||||
| Depreciation | |||||
| Total operating costs and expenses | |||||
| COST OF REVENUES | |||||
| GROSS PROFIT | |||||
| OPERATING EXPENSES: | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Research and development | |||||
| Total operating expenses | |||||
| LOSS FROM OPERATIONS | |||||
| OTHER INCOME (EXPENSE) | |||||
| Interest income | |||||
| Interest expense | |||||
| Other income | |||||
| Total other income, net | |||||
| LOSS BEFORE INCOME TAXES | |||||
| PROVISION FOR INCOME TAXES | |||||
| Net loss from continued operations | |||||
| Net income (loss) from discontinued operations | |||||
| NET LOSS | |||||
| Less: net loss attributable to noncontrolling interest | |||||
| Net income attributable to the Company | |||||
| OTHER COMPREHENSIVE INCOME | |||||
| Foreign currency translation adjustment attributable to non-controlling interests | |||||
| Foreign currency translation adjustment attributable to the Company | |||||
| Comprehensive income | |||||
| Foreign currency translation adjustment from continued operations | |||||
| Foreign currency translation adjustment from discontinued operations | |||||
| Foreign currency translation adjustment | |||||
| TOTAL COMPREHENSIVE LOSS | |||||
| Basic earnings per share (in Dollars per share) | |||||
| Diluted earnings per share (in Dollars per share) | |||||
| Less: comprehensive loss attributable to noncontrolling interest | |||||
| COMPREHENSIVE LOSS ATTRIBUTABLE TO JRSIS HEALTH CARE CORPORATION | |||||
| WEIGHTED AVERAGE NUMBER OF COMMON SHARES | |||||
| Basic (in Shares) | |||||
| Weighted average number of shares outstanding (Diluted) (in Shares) | |||||
| LOSS PER SHARE | |||||
| Net loss - basic (in Dollars per share) | |||||
| Diluted earnings per share (in Dollars per share) | |||||
| NET LOSS ATTRIBUTABLE TO JRSIS HEALTH CARE CORPORATION | |||||
Loading...